Literature DB >> 10230589

Heidelberg retina flowmeter parameters at the papilla in healthy subjects.

S M Griesser1, A Lietz, S Orgül, A Schötzau, P Hendrickson, J Flammer, I O Haefliger.   

Abstract

PURPOSE: To assess the Heidelberg Retina Flowmeter (HRF) parameters "volume", "flow", and "velocity", at the papilla in healthy subjects.
METHODS: HRF measurements were taken at the papilla (5 degrees x 20 degrees), superficially at level of the retina and at the bottom of the excavation. The effect of increasing frame size (1 x 1 to 50 x 50 pixels) on HRF values was assessed in ten subjects. HRF parameters were calculated (50 x 50 pixels) for 150 eyes of 150 subjects. To assess short-term reliability, measurements were repeated five times in ten subjects.
RESULTS: With 50 x 50 pixels the location of the frame had no influence on HRF values. Reliability was > 90%. Values were significantly higher (p < 0.001) in the superficial than in the deeper papillary layers. The correlation between HRF parameters was good (r2 > 0.85).
CONCLUSIONS: A low magnification (5 degrees x 20 degrees) and a 50 x 50 frame allows a global assessment of HRF parameters at the papilla with high reliability. In healthy eyes, the HRF values are influenced by the level where measurements are made at the papilla. This might be of importance in glaucoma patients with excavated papilla.

Entities:  

Mesh:

Year:  1999        PMID: 10230589     DOI: 10.1177/112067219900900105

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  2 in total

1.  Scanning laser Doppler flowmeter study of retinal blood flow in macular area of healthy volunteers.

Authors:  I Kimura; K Shinoda; T Tanino; Y Ohtake; Y Mashima; Y Oguchi
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

2.  Reproducibility of circadian retinal and optic nerve head blood flow measurements by Heidelberg retina flowmetry.

Authors:  C P Jonescu-Cuypers; A Harris; K U Bartz-Schmidt; L Kagemann; A S Boros; U E Heimann; B H Lenz; R-D Hilgers; G K Krieglstein
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.